Narrative Review: Assessment of Neisseria gonorrhoeae Infections Among Men Who Have Sex With Men in National and Sentinel Surveillance Systems in the United States by Weston, Emily J. et al.
Narrative Review: Assessment of Neisseria gonorrhoeae 
Infections Among Men Who Have Sex With Men in National and 
Sentinel Surveillance Systems in the United States
Emily J. Weston, MPH*, Robert D. Kirkcaldy, MD, MPH*, Mark Stenger, MA*, Eloisa Llata, 
MD, MPH*, Brooke Hoots, PhD, MSPH†, and Elizabeth A. Torrone, PhD, MSPH*
*Division of STD Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB 
Prevention, Centers for Disease Control and Prevention, Atlanta, GA
†Division of HIV/AIDS Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB 
Prevention, Centers for Disease Control and Prevention, Atlanta, GA
Abstract
To assess trends in Neisseria gonorrhoeae among gay, bisexual, and other men who have sex with 
men (MSM), we reviewed existing and published gonorrhea surveillance data in the United States. 
Data identified in this review include the following: national gonorrhea case report data and data 
from 3 other surveillance programs, the Gonococcal Isolate Surveillance Project (GISP), the STD 
Surveillance Network (SSuN), and National HIV Behavioral Surveillance.
Rates of reported cases of gonorrhea among men increased 54.8% in 2006 to 2015 compared with 
a 2.6% increase among women. Since 2012, the rate of reported gonorrhea cases among men 
surpassed the rate among women; the male-to-female case rate ratio increased from 0.97 in 2012 
to 1.31 in 2015. The proportion of gonococcal urethral isolates collected in the Gonococcal Isolate 
Surveillance Project that were collected from MSM increased from 21.5% to 38.1% in 2006 to 
2015. In 2009 to 2015, the percent of MSM who tested positive for rectal and oropharyngeal 
gonorrhea in sexually transmitted disease (STD) clinics increased by 73.4% and 12.6%, 
respectively. Estimated rates of gonorrhea among MSM increased by 151% in 2010 to 2015 in 
jurisdictions participating in the STD Surveillance Network. Data from the National HIV 
Behavioral Surveillance demonstrate that testing for gonorrhea among MSM increased by 23.1% 
between 2011 and 2014.
Together, surveillance data suggest a disproportionate burden of gonorrhea among MSM in the 
United States and suggest increases in both screening and disease in recent years. Because each 
data source has inherent limitations and biases, examining these data from different systems 
together strengthens this conclusion.
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BACKGROUND
Infection with Neisseria gonorrhoeae in men can occur in the oropharynx, genitals, and 
rectum. Although often asymptomatic, infections can result in dysuria, discharge, 
epididymitis, anal itching, soreness, bleeding, or painful bowel movements.1 In addition, 
gonococcal infections can elicit mucosal inflammation facilitating HIV transmission and 
acquisition.2–4 To prevent gonorrhea-associated morbidity and associated sequelae, effective 
prevention and control efforts are needed and should be targeted to populations at increased 
risk. From 2002 to 2012, rates of reported gonorrhea cases in the United States have been 
higher among women, most likely because of screening practices and recommendations.5,6 
Since 2013, however, the rate of reported gonorrhea cases among men have been higher than 
the rates among women, suggesting a change in the epidemiology of gonorrhea in the United 
States, such as increasing incidence among gay, bisexual, and other men who have sex with 
men (MSM).7 To better describe the current epidemiology of gonorrhea among men in the 
United States, we reviewed available national and sentinel surveillance data and describe 
trends in gonorrhea among MSM.
METHODS
We reviewed existing and published data from national and sentinel sources on gonococcal 
infection among men in the United States. Data identified for use in this summary include 
national gonorrhea case report data from the National Notifiable Disease Surveillance 
System and data from the Gonococcal Isolate Surveillance Project (GISP), the STD 
Surveillance Network (SSuN), and the National HIV Behavioral Surveillance (NHBS).
Case Report Data
State and local health departments report cases of gonorrhea weekly to the Centers for 
Disease Control and Prevention (CDC) National Notifiable Disease Surveillance System.8 
Case reports include a limited set of required demographic data elements usually provided 
on laboratory reports (e.g., age and gender) and may include optional data elements 
collected during case investigations (e.g., gender of sex partners and HIV status).9
We reviewed trends in reported gonorrhea cases in 2006 to 2015 among men by age, race/
ethnicity (using US census population bridged race files), and census region (Midwest, 
Northeast, South, and West). To investigate trends by sex, we calculated the male-to-female 
rate ratio using the rate of reported male cases and the rate of reported female cases (rate 
ratio = rate for males/rate for females). We assumed that an increasing rate ratio suggests 
increasing gonorrhea rates among MSM.10,11
Although gender of sex partner is not a required data element for reported cases of 
gonorrhea and not routinely reported in national surveillance summaries, we investigated the 
proportion of male cases that were reported among MSM in jurisdictions reporting gender of 
sex partner data for at least 70% of their male cases. We used a 70% cut point because it has 
been previously used when assessing variable completeness for other reportable STDs.7
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Gonococcal Isolate Surveillance Project
Gonococcal Isolate Surveillance Project is an ongoing CDC-supported surveillance system 
that monitors gonococcal antimicrobial susceptibility in selected STD clinics in 25 to 30 
cities each year.12 Each month, up to 25 N. gonorrhoeae urethral isolates are collected from 
consecutive men with gonococcal urethritis attending participating STD clinics and 
submitted to regional laboratories for antimicrobial susceptibility testing. Demographic and 
clinical data (such as gender of sex partner) are abstracted from medical records by clinic 
staff and submitted each month to the CDC. Gender of sex partner data are collected in 
accordance with local clinic practice and can include chart notation from previous visits 
based on patient self-report of sexual orientation or reported gender of sex partners (from the 
previous 3, 6, or 12 months).12 Men reporting gay or bisexual sexual orientation or who 
reported recent male sex partners were categorized as MSM. Men who reported sex only 
with women were categorized as MSW. We report the proportion of submitted isolates 
collected from MSM for each year from 2006 to 2015; data from other subgroups in GISP 
are presented elsewhere.12
STD Surveillance Network
STD Surveillance Network is a CDC-supported surveillance system comprising selected 
state and city health departments. It addresses gaps in national case data through 2 activities: 
(a) enhanced case-based gonorrhea surveillance, referred to as the “population component,” 
and (b) sentinel surveillance in key facilities, including STD clinics, referred to as the 
“facility component.” STD Surveillance Network jurisdictions participating in the 
population component identify a random sample of gonorrhea cases reported from all 
providers for administration of a standardized behavioral interview. In the facility 
component, demographic, behavioral, and clinical information is collected from all patients 
presenting for care in participating STD clinics (the number of clinics under surveillance 
ranged from 28 clinics in 2009 to 25 clinics in 2015). For the population component, men 
who identified as gay or bisexual or who reported male sex partners in the previous 12 
months were categorized as MSM. For the facility component, men who identified as gay or 
bisexual, or who reported ever having male sex partners were categorized as MSM. For both 
activities, men who reported only female sex partners, or those who did not report any recent 
sex partners but who identified as heterosexual were categorized as MSW. Six jurisdictions 
(Baltimore, Maryland; California excluding San Francisco; New York City, New York; 
Philadelphia, Pennsylvania; San Francisco, California; and Washington) provided data from 
continuously participating STD clinics for the facility component in 2009 to 2015. The same 
6 jurisdictions provided data for the population component in 2010 to 2015; in addition, 4 
other jurisdictions (Multnomah County, Oregon; Minnesota; Massachusetts; and Florida) 
provided data in 2015.
We used enhanced case investigation data from the population component to calculate the 
weighted proportion of gonorrhea cases attributable to MSM, MSW, and women in the 10 
jurisdictions participating in 2015. To examine temporal trends, we report published 
estimates of calculated incidence of gonorrhea diagnoses among MSM from the population 
component (calculated using MSM population estimates at the county level) in the 6 
jurisdictions participating in 2010 to 2015.13 Using SSuN facility data from 6 jurisdictions 
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participating in 2009 to 2015, we assessed the annual number of unique facility visits by 
MSM, the percentage of MSM tested for gonorrhea by anatomical site, and the percent 
positive (positivity) by anatomical site.
National HIV Behavioral Surveillance
National HIV Behavioral Surveillance is a CDC-supported surveillance system that monitors 
HIV-associated behaviors and HIV prevalence in 20 cities with high AIDS burden. Cross-
sectional behavioral data were collected from MSM recruited for interviews through venue-
based, time-space sampling in 2011 and 2014.14 Men attending venues frequented by MSM 
(i.e., bars, dance clubs, gyms, restaurants, parks, street locations, and social organizations) 
were systematically screened for eligibility. Eligibility criteria were age at least 18 years, 
residence in a participating city, ever having had sex with another male, and ability to 
complete the interview in English or Spanish. Consenting MSM were interviewed by trained 
interviewers using a standardized questionnaire covering demographics, HIV-associated 
behaviors, use of HIV prevention and testing services, and STD testing history.
Men who have sex with men with complete and valid interview data who were currently 
sexually active, defined as having at least 1 male partner in the past 12 months, were 
included in analyses. We report estimates for the proportion of MSM who self-reported 
gonorrhea testing in the past 12 months for years 2011 and 2014, including a prevalence 
ratio comparing the 2 periods adjusting for key epidemiologic characteristics. Testing was 
ascertained from the question, “In the past 12 months, were you tested by a doctor or other 
healthcare provider for a sexually transmitted disease like gonorrhea, chlamydia, or syphilis? 
Do not include tests for HIV or hepatitis.” If the participant answered yes, they were then 
asked separately if they were tested for gonorrhea.
RESULTS
Case Report Data
In 2015, 221,070 cases of gonorrhea were reported among men corresponding to a rate of 
140.9 cases per 100,000 men. The rate increased by 54.8% from a historic low rate in 2009 
(91.0 cases per 100,000 men; Fig. 1). In contrast, the rate of reported gonorrhea among 
women in 2015 (107.2 cases per 100,000 women) increased by 2.6% from the historic low 
rate in 2009 (104.5 cases per 100,000 women).
The rate of reported gonorrhea increased among all male age groups in 2006 to 2015 except 
among those younger than 20 years. In 2006 to 2015, gonorrhea case rates among men 
increased among all race/ethnicities except among black men, despite black men continuing 
to have the highest rates. By census region, rates among men increased substantially in 2006 
to 2015 in the West (75.7%) and in the Northeast (62.5%), whereas rates in the South 
increased slightly (2.7%) and decreased in the Midwest (0.8%). It is likely that rates by 
region and by race/ethnicity are intertwined as the largest increase in rates (228.6%) among 
white men was observed in the West and the rates among black males decreased by 28.9% in 
the Midwest and 20.4% in the South in 2006 to 2015.
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Starting in 2012 (Fig. 1), there was an increase in the overall male-to-female case rate ratio 
from 0.97 in 2012 to 1.31 in 2015. By region, only the West had a male-to-female rate ratio 
greater than 1.0 in 2006 to 2015, although the Northeast had a similar trend to the United 
States overall in 2012 to 2015 (Fig. 1A). Every age group greater than 24 years had a male-
to-female rate ratio greater than 1.0 in 2006 to 2015 (Fig. 1B), and older age groups 
generally exhibited higher rate ratios. The male-to-female rate ratio increased among nearly 
all racial/ethnic groups. The increases were most pronounced among Asian/Pacific Islanders, 
Hispanics or Latinos, and whites. Although an increase in the rate ratio was not clearly 
observed among blacks, the ratio was greater than 1.0 during the entire analytic period (Fig. 
1C).
In 2006, only 8.9% of reported gonorrhea cases had corresponding gender of sex partner 
data, and by 2015, that increased to 9.7%. When restricted to the 4 jurisdictions with greater 
than 70% completion of this variable, 41.0% of cases were classified as MSM, 41.4% of 
cases were classified as MSW, and 17.6% of cases were had unknown gender of sex partner. 
No jurisdictions reported at least 70% of cases with gender of sex partner each year in 2006 
to 2015, so temporal trends among MSM were not able to be determined.
Gonococcal Isolate Surveillance Project
In 2006 to 2015, a total of 55,336 gonococcal urethral isolates (range, 5032 [2014]–5962 
[2006]) were collected in GISP. Of these, 16,504 (29.0%) were collected from MSM. The 
proportion of urethral isolates from MSM increased from 21.5% in 2006 to 38.1% in 2015 
(Fig. 2). When stratified, the proportion of isolates that were from MSM increased in almost 
all categories. For example, among black men, the proportion of isolates that were collected 
from MSM increased from 6.4% to 20.3%, and among men aged 20 to 29 years, the 
proportion of isolates that were from MSM increased from 39.3% to 77.0% in 2006 to 2015; 
among Asian men, the proportion of isolates collected from MSM decreased by 10.7%. The 
proportion of isolates from all 4 census regions collected from MSM also increased in 2006 
to 2015; however, it was increases in the Midwest (180.0%), Northeast (178.2%), and South 
(187.4%) that were largest.
Among MSM specifically, the largest percentages of isolates collected in 2006 to 2015 were 
from white men (42.4%), were between the ages of 20 and 29 years (48.6%), were from the 
West (63.5%), had a history of gonorrhea (54.8%), had no gonococcal infections in the 
previous 12 months (68.7%), and were not HIV infected (65.0%).
STD Surveillance Network
In the SSuN population data in 2010 to 2015, the number of MSM diagnosed as having 
gonorrhea in the 6 sites continuously participating in SSuN increased from 14,993 in 2010 to 
38,848 in 2015, a 160% absolute number increase. The rate of reported gonorrhea cases 
among MSM in these jurisdictions was 1369 cases per 100,000 in 2010 and increased by 
150.9% to 3435 cases per 100,000 in 2015 (Fig. 3). In 2015, the rate among MSM was 30.9 
times the rate among men who have sex with women only (3435 vs. 111 per 100,000 
population).
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In the SSuN facility data in 2009 to 2015, 941,223 patients had at least 1 visit to SSuN STD 
clinics, of which 141,396 (15.0%) patients were MSM. During this time, the number of 
MSM with at least 1 visit increased from 16,799 in 2009 to 27,182 in 2015, and MSM made 
up an increasing proportion of total clinics patients (10.6% in 2009 to 25.8% in 2015). In 
2009 to 2015, the proportion of MSM tested for oropharyngeal and urogenital gonorrhea 
was stable (67.4%–66.1% and 85.2%–86.3%, respectively) and the proportion of MSM 
tested for rectal gonorrhea decreased (49.9%–45.4%); however, because the MSM clinic 
population increased during the same period, the absolute number of MSM tested for 
gonorrhea at any anatomical site increased by 66.8% from 2009 to 2015 (15,029 to 25,072).
In 2009 to 2015, 16.6% of MSM tested positive for gonorrhea at any anatomical site; 
positivity for rectal gonorrhea was 11.7%, oropharyngeal gonorrhea was 7.3%, and 
urogenital gonorrhea was 9.9%. Over time, positivity decreased by 12.9% for urogenital 
gonorrhea; however, the MSM clinic population increased during this time and the overall 
number of MSM diagnosed as having urogenital gonorrhea increased by 42.8% (1443 to 
2061). During this same period, positivity increased by 12.6% for oropharyngeal gonorrhea 
and 72.4% for rectal gonorrhea (Fig. 4). As both positivity at extragenital sites and the MSM 
clinic population increased during this period, the overall number of MSM diagnosed as 
having oropharyngeal gonorrhea increased by 78.7% (757 to 1353) and the overall number 
of MSM diagnosed as having rectal gonorrhea increased by 155.0% (725 to 1849).
National HIV Behavioral Surveillance
National HIV Behavioral Surveillance data came from 20 cities in 2011 (n = 9256) and 2014 
(n = 9640). Approximately 40% of MSM were white, non-Hispanic or Latino, and aged 18 
to 29 years; 70% of MSM had some college education or higher and had health insurance; 
and 80% of MSM were HIV negative. However, the percent of HIV-positive MSM increased 
overall between 2011 and 2014. The prevalence of self-reported gonorrhea testing among 
MSM increased from 38.8% in 2011 to 47.8% in 2014. After adjusting for race, age, health 
insurance, self-reported HIV status, number of sex partners, and city, the adjusted prevalence 
ratio comparing the 2 periods was 1.18 (confidence interval, 1.14–1.22). Testing for 
gonorrhea was more prevalent among MSM who were younger, had more education, had 
health insurance, and were HIV positive. Testing for gonorrhea increased among all 
demographic subgroups.
DISCUSSION
A review of available national and sentinel surveillance data suggests that MSM bear a 
disproportionate burden of gonorrhea in the United States and that in recent years, an 
increasing number of MSM are being diagnosed as having gonorrhea. National case report 
data show increases in the rates of reported diagnoses among men in 2012 to 2015. Although 
few case reports contained information on gender of sex partner, the increasing male-to-
female case rate ratio suggests increases in the number of diagnosed infections among 
MSM. Using county-level estimates of the MSM population to estimate rates, the rate 
among MSM was 30.9 times the rate among men who have sex with women only in SSuN 
jurisdictions in 2015, and in 2010 to 2015, the rate among MSM increased by 151%.
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Increases in diagnoses among MSM may reflect increases in screening, increases in 
incidence, or a combination of both. Trends in the total number of MSM screened for 
gonorrhea are not available; however, between 2011 and 2014, more MSM participating in 
NHBS reported having been tested for gonorrhea, and in 2009 to 2015, the number of MSM 
tested for gonorrhea in SSuN STD clinics increased by almost 70%. Combined, this suggests 
that screening among MSM has likely increased. Increased screening may be due to the 
increased availability of extragenital testing, as well as more frequent STD screening as a 
result of increased preexposure prophylaxis use among MSM. Surveillance data also suggest 
that concurrent with increases in screening, incidence among MSM may have increased. In 
2006 to 2015, the percentage of urethral isolates from MSM in GISP increased by 77% 
suggesting increases in symptomatic MSM seeking care over time, which may be a marker 
of increased incidence. In addition, in 2009 to 2015, positivity estimates among MSM in 
SsuN’s facility component show that the proportion of MSM testing positive is increasing, 
especially among those with rectal and oropharyngeal gonococcal infections, also suggesting 
increased incidence. Increases in incidence may reflect changes in sexual behavior, 
including increased condomless sex due to preexposure prophylaxis and expanded sexual 
networks due to use of geolocating apps for sexual partners.15
In combination, these national and sentinel surveillance data provide insight into the 
gonorrhea epidemic. However, each of the data sources reviewed has limitations. Although 
national case data allow for the analysis of trends in reported diagnoses over time and by key 
demographics such as age and race/ethnicity, most reported gonorrhea cases (>90% in 2015) 
were missing information on gender of sex partner. Lack of information on gender of sex 
partner on reported gonorrhea cases is not surprising; case report forms may not allow for 
the collection of the sexual behavior data, or the only information available to the local 
health department is from the laboratory report, which rarely contains sexual behavior data.
16
 As a result, the male-to-female case rate ratio can be used as a proxy for gonorrhea rates 
among MSM when gender of sex partner is unknown.11 However, gonococcal infection can 
be asymptomatic in men, so observed case rates are heavily influenced by screening 
practices. Observed increases among men may be a reflection of increased screening or 
could represent other epidemics among higher-risk populations, such as commercial sex 
workers or those in correctional facilities.
Gonococcal Isolate Surveillance Project was established to provide information on 
gonococcal antimicrobial susceptibility patterns. Epidemiologic data, including gender of 
sex partner, are collected with the susceptibility test results, so these data can also provide a 
snapshot of symptomatic men seeking care for urethral gonorrhea in STD clinics. Because 
GISP uses a standardized protocol (e.g., only collecting the first 25 urethral isolates from 
symptomatic men visiting STD clinics each month), the data are not heavily influenced by 
changes in screening practices. In 2006 to 2015, an increasing proportion of men included in 
GISP were MSM, suggesting increases in gonorrhea among MSM. In addition, it is also 
possible that the population seeking care in STD clinics has changed over time and increases 
in the proportion of isolates that are among MSM reflect changes in the clinic population 
(e.g., more MSM are attending STD clinics either due to increased incidence among MSM 
or changes in where MSM access STD-related services).
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STD Surveillance Network conducts surveillance for gonorrhea through enhanced case 
investigations in the population component. Enhanced patient interviews among those 
diagnosed as having gonorrhea allows for collection of data usually missing from case 
reports, including gender of sex partner. Because interviews are conducted on a random 
sample, estimates are weighted to be representative of all cases in the jurisdiction and can be 
used to document the disproportionate burden of gonorrhea among MSM in some 
jurisdictions. In addition, use of MSM population estimates as denominators for rates has 
allowed for estimation of MSM and MSW rates and data from 2010 to 2015 document 
increasing rates among MSM. However, these rates are based on diagnosis of gonorrhea. 
Because gonorrhea can be asymptomatic, observed diagnosis rates in SSuN are influenced 
by changes in screening and increases among MSM could be attributable to increased 
screening, particularly of extragenital anatomical sites.
STD Surveillance Network also conducts sentinel surveillance in STD clinics, providing 
information on the health care–seeking behavior of MSM as well as estimates of gonorrhea 
positivity which can account for changes in screening coverage. In 2009 to 2015, positivity 
at extragenital sites (i.e., rectal and oropharyngeal) increased suggesting possible increases 
in incidence among MSM. Urethral positivity, on the other hand, was stable suggesting no 
change in incidence. However, screening practices may vary between SSuN clinics, which 
may impact observed positivity. In addition, these estimates are limited to persons seeking 
care in STD clinics, which may not be representative of all persons at risk for gonorrhea. 
Finally, jurisdictions participating in both the population and facility components of SSuN 
were not randomly selected; therefore, trends may not be representative of all jurisdictions.
Results from NHBS show a higher rate of gonorrhea testing in 2014 than in 2011 among 
MSM in participating surveillance sites. This surveillance system describes populations that 
are at highest risk for HIVand allow for a glimpse into special populations, such as MSM, 
and surveillance is not just limited to participants in STD clinics. The data, however, are 
limited to 2 time points and cannot be interpreted as a trend. In addition, the reported data 
have not been weighted to account for complex sampling methodologies. As described, the 
data on STD testing are self-reported and subject to social desirability bias and recall error. 
Lastly, NHBS is not nationally representative; therefore, the results may not be generalizable 
to all MSM in participating cities or to all MSM. However, the results match trend data that 
are available from SSuN regarding increased testing among MSM.
Finally, for all data sources, there is the potential for mis-classification of men as MSM or 
MSW. Some men may be reluctant to disclose their behaviors, especially those with other 
male sex partners, and therefore may have been misclassified as MSW. Thus, the data 
presented in this review may be an underestimate of disease among MSM and trends may be 
biased if disclosure patterns changed over time. In addition, nonresponse during patient 
interviews and missing data on gender of sex partner in medical records also affect the 
validity of data.
This review of existing surveillance data sources provides insight into the current 
epidemiology of gonorrhea among MSM and suggests that more MSM are being diagnosed 
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as having gonorrhea, which is likely due to a combination of both increased disease 
incidence and increased screening.
Enhancing current surveillance efforts could help to better monitor gonorrhea among MSM. 
For example, jurisdictions that routinely collect gender of sex partner data for reported 
gonorrhea cases should examine trends among MSM. Jurisdictions that are not able to 
capture gender of sex partner information for all cases could calculate the male-to-female 
case rate ratio, and if resources allow, jurisdictions could implement an SSuN-like 
methodology by taking a random sample and collecting more complete data for those cases. 
In both situations, jurisdictions could take advantage of the recently released MSM county-
level population denominators to calculate rates among MSM.17 In addition, mathematical 
modeling may help disentangle the impact of increased incidence and increased screening 
on observed diagnoses. Beyond understanding these trends, additional efforts and 
approaches are needed to develop and identify effective and appropriate prevention and 
control measures to address gonococcal infections among MSM.
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Figure 1. 
A, Rates of reported gonorrhea cases by sex and male-to-female rate ratio*, 2006–2015. B–
D, Male-to-female gonorrhea rate ratio by region, age group, and race/ethnicity*, 2006–
2015. *All figures calculated as follows: male rate/female rate.
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Figure 2. 
Percentage of urethral N. gonorrhoeae isolates collected from MSM, GISP, 2006 to 2015.
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Figure 3. 
Estimated case rate among MSM, MSW, and rate of reported cases among women*, SSuN, 
2010 to 2015. * Estimated case rate for MSM, MSW; reported case rate for women. **Data 
not available for 2014; 2014 data imputed from 2013 to 2015 data by linear interpolation; 
trend lines for MSW and women overlap. Figure taken from Stenger et al.13
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Figure 4. 
Proportion of MSM* attending STD clinics testing positiveᵻ for gonorrhea by anatomical 
site, SSuN, 2009 to 2015. * MSM = gay, bisexual and other MSM (collectively referred to as 
MSM). ᵻResults based on data obtained from number of positive unique MSM patients tested 
by anatomical site for gonorrhea attending STD clinics in Baltimore, California, New York 
City, Philadelphia, San Francisco, and Washington.
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